NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MetrioPharm AG

MetrioPharm AG

Private
ZurichHealthcare & Life Scienceshttps://www.metriopharm.com/

Last Round

VC Round

Oct 1, 2023

Est. Valuation

$163.04M

Total Funding Raised

$59.64M

Company Overview

MetrioPharm AG is a clinical-stage biopharmaceutical company that develops first-in-class, self-regulating immunomodulators for the treatment of inflammatory and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall molecule drugdrug discoveryimmunomodulatoranti-inflammatoryclinical developmentmetabolic modulatoroxidative stressbiotech startupclinical trialsdrug licensingpharma R&Ddrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MetrioPharm AG Comps

Public and private peers based on sector, stage, and business model.

MetrioPharm AG comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MetrioPharm AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 1, 2023
GrantOct 12, 2022
VC RoundOct 1, 2022
GrantNov 1, 2021
Series EOct 12, 2021
Series D
Dec 11, 2018

MetrioPharm AG Investors

Notable investors and investment history

MetrioPharm AG investors
InvestorRounds
Duchenne UKGrant
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 79% MoM, from 616 to 1.1K.

  • Oct 1, 2022

    $6.3M raised in a VC Round.

MetrioPharm AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MetrioPharm AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MetrioPharm AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range21
Year Founded2007
Last FundingOct 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.